S

Syndax Pharmaceuticals

D
SNDX
USD
0.16
(0.9627%)
Market Closed
125,475.00
حجم التداول
-3.94
الربح لكل سهم
-
العائد الربحي
-4.935294
P/E
1,427,916,887.24
حجم السوق
اليوم
0.9627%
1 اسبوع
-22.026%
1 شهر
-15.295%
6 اشهر
-22.566%
12 اشهر
14.072%
بداية السنة
-22.315%
كل الوقت
0%
avatar
sara abdelazim
عدد النقاط
112
عدد التوصيات
2

Title:
Syndax Pharmaceuticals

Sector:
Healthcare
Industry:
Biotechnology
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.
هل تحتاج مساعدة او لديك استفسار؟